Discover Funding Opportunities
Search by topic, keyword, or describe what you need in plain language.
Sign in to match opportunities to your profile.
Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
The NICHD has a state-of-the-art Chemical Synthesis and Optimization Facility for advancing both non-hormonal contraceptive and reproductive health related product development. This facility has the capabilities and capacity for preclinical services including Investigational Device Exemption (IDE) or Investigational New Drug (IND)-enabling studies (e.g., protein generation, X-ray crystallography, high throughput screening, structure activity relationships, hit-to-lead generation, drug metabolism). The long-term objective is to enable a preclinical candidate for IND/IDE study(ies) that offers a safe therapeutic option in the field of contraception, and/or reproductive health related indications (pending contractor availability and available funding). This grant opportunity provides access to specialized facilities and services through the National Institutes of Health to support preclinical development of reproductive health products.